Sentiment Trading

Opus Genetics, a clinical-stage biopharmaceutical company, is dedicated to developing innovative ophthalmic therapies and making a lasting impact in the biotechnology sector.

Opus Genetics Inc. is advancing its gene therapy programs for inherited retinal diseases, showcasing promising results and positioning itself as a significant player in the biotechnology sector.